Business Description
Edesa Biotech Inc
NAICS : 325412
SIC : 3741
ISIN : CA85855A3029
Description
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 48.28 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.01 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -59 | |||||
3-Year EPS without NRI Growth Rate | -58.1 | |||||
3-Year FCF Growth Rate | -58.5 | |||||
3-Year Book Growth Rate | -22 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 40.01 | |||||
9-Day RSI | 42.12 | |||||
14-Day RSI | 43.75 | |||||
6-1 Month Momentum % | 0.66 | |||||
12-1 Month Momentum % | -21.47 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.97 | |||||
Quick Ratio | 1.97 | |||||
Cash Ratio | 1.3 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -30.8 | |||||
Shareholder Yield % | -14.09 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -106.32 | |||||
ROA % | -83.67 | |||||
ROIC % | -300.21 | |||||
ROC (Joel Greenblatt) % | -7417 | |||||
ROCE % | -109.62 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 3.28 | |||||
Price-to-Tangible-Book | 6.51 | |||||
EV-to-EBIT | -1.44 | |||||
EV-to-EBITDA | -1.49 | |||||
EV-to-Forward-EBITDA | -1.54 | |||||
EV-to-Forward-Revenue | 5.15 | |||||
EV-to-FCF | -1.71 | |||||
Price-to-Net-Current-Asset-Value | 6.81 | |||||
Price-to-Net-Cash | 22.14 | |||||
Earnings Yield (Greenblatt) % | -69.44 | |||||
FCF Yield % | -44.53 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:EDSA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Edesa Biotech Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -2.379 | ||
Beta | 0.35 | ||
Volatility % | 57.29 | ||
14-Day RSI | 43.75 | ||
14-Day ATR ($) | 0.256833 | ||
20-Day SMA ($) | 4.38355 | ||
12-1 Month Momentum % | -21.47 | ||
52-Week Range ($) | 2.4603 - 8.3331 | ||
Shares Outstanding (Mil) | 3.22 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Edesa Biotech Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Edesa Biotech Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Edesa Biotech Inc Frequently Asked Questions
What is Edesa Biotech Inc(EDSA)'s stock price today?
The current price of EDSA is $4.43. The 52 week high of EDSA is $8.33 and 52 week low is $2.46.
When is next earnings date of Edesa Biotech Inc(EDSA)?
The next earnings date of Edesa Biotech Inc(EDSA) is 2024-08-09 Est..
Does Edesa Biotech Inc(EDSA) pay dividends? If so, how much?
Edesa Biotech Inc(EDSA) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |